tenofovir has been researched along with Bone Diseases in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 14 (82.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, PL; Bekker, LG; Buchbinder, SP; Chariyalertsak, S; Glidden, DV; Grant, RM; Grinsztejn, B; Guanira, J; McMahan, V; Mulligan, K; Schechter, M | 1 |
| Puthanakit, T; Siberry, GK | 1 |
| Bandera, A; Crivellaro, C; Gori, A; Guerra, L; Mangioni, D; Messa, C; Muscatello, A; Squillace, N | 1 |
| Drevets, DA; Lockhart, SM | 1 |
| Bedimo, R; Brown, G; Castanon, R; Cutrell, J; Drechsler, H; Farukhi, I; Gao, A; Maalouf, NM; Tebas, P; Zhang, S | 1 |
| Horn, TH; Paltiel, AD; Walensky, RP | 1 |
| Effa, EE; Okonkwo, RI; Weidmann, AE | 1 |
| Bergmann, JF; Champion, K; Clevenbergh, P; Collet, C; de Vernejoul, MC; Evans, J; Fernandez, S; Lopes, A; Morgand, M; Ostertag, A; Sellier, P; Souak, S; Trout, H | 1 |
| Baldelli, S; Cattaneo, D; Clementi, E; Gervasoni, C; Meraviglia, P; Minisci, D; Rizzardini, G | 1 |
| Bedimo, R; Myers, J; Rosenblatt, L | 1 |
| Coumbis, J; Myers, J; Nkhoma, ET; Rosenblatt, L; Villasis-Keever, A | 1 |
| Foster, C; Gibb, DM; Lyall, H; Olmscheid, B; Pearce, G; Zhang, S | 1 |
| Carr, A; Hoy, J | 1 |
| Cotter, AG; Powderly, WG | 1 |
| Brim, NM; Cu-Uvin, S; Hu, SL; O'Bell, JW | 1 |
5 review(s) available for tenofovir and Bone Diseases
| Article | Year |
|---|---|
Bone health in children and adolescents with perinatal HIV infection.
Topics: Adenine; Adolescent; Anti-HIV Agents; Bone Density; Bone Diseases; Child; HIV Infections; Humans; Organophosphonates; Prevalence; Tenofovir | 2013 |
Renal and Bone Adverse Effects of a Tenofovir-Based Regimen in the Treatment of HIV-Infected Children: A Systematic Review.
Topics: Anti-HIV Agents; Bone Diseases; Child; HIV Infections; Humans; Kidney Diseases; Randomized Controlled Trials as Topic; Tenofovir; Treatment Outcome | 2016 |
Systematic review of renal and bone safety of the antiretroviral regimen efavirenz, emtricitabine, and tenofovir disoproxil fumarate in patients with HIV infection.
Topics: Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Bone Diseases; Clinical Trials as Topic; Cyclopropanes; Drug Interactions; Emtricitabine; HIV Infections; Humans; Incidence; Kidney Diseases; Tenofovir; Treatment Outcome | 2016 |
Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?
Topics: Adenine; Adult; Africa South of the Sahara; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Diseases; Child; Child, Preschool; Congenital Abnormalities; Disease Models, Animal; Drug Resistance, Viral; Female; Health Services Accessibility; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Macaca; Mitochondria; Nevirapine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Zidovudine | 2009 |
Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Diseases; Endocrine System Diseases; HIV; HIV Infections; Humans; Hypogonadism; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir | 2011 |
1 trial(s) available for tenofovir and Bone Diseases
| Article | Year |
|---|---|
Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis.
Topics: Absorptiometry, Photon; Adult; Anti-HIV Agents; Bone Density; Bone Diseases; Emtricitabine; Female; Follow-Up Studies; HIV Infections; Homosexuality, Male; Humans; Male; Patient Compliance; Pre-Exposure Prophylaxis; Tenofovir | 2017 |
11 other study(ies) available for tenofovir and Bone Diseases
| Article | Year |
|---|---|
Focal bone lesions in HIV-positive patient treated with tenofovir.
Topics: Adenine; Anti-HIV Agents; Bone Diseases; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Tenofovir | 2014 |
Reversible bone lesions induced by tenofovir disoproxil fumarate.
Topics: Adenine; Adult; Bone Diseases; Female; Humans; Organophosphonates; Radionuclide Imaging; Tenofovir | 2014 |
Tenofovir in HIV-infected children. Antiretroviral efficacy, but beware of adverse effects on bone and the kidneys.
Topics: Adenine; Anti-HIV Agents; Bone Diseases; Child; Dose-Response Relationship, Drug; HIV Infections; Humans; Kidney Diseases; Medication Errors; Organophosphonates; Tenofovir | 2014 |
Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver disease.
Topics: Absorptiometry, Photon; Adult; Aged; Anti-Retroviral Agents; Bone Density; Bone Diseases; Bone Remodeling; Cross-Sectional Studies; Gonadal Steroid Hormones; Hepatitis C, Chronic; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; Tenofovir | 2016 |
The Epi-TAF for Tenofovir Disoproxil Fumarate?
Topics: Anti-HIV Agents; Bone Diseases; Cost-Benefit Analysis; HIV Infections; Humans; Kidney Diseases; Tenofovir; United States | 2016 |
Disrupted trabecular bone micro-architecture in middle-aged male HIV-infected treated patients.
Topics: Adult; Anti-Retroviral Agents; Bone Density; Bone Diseases; Cancellous Bone; Cross-Sectional Studies; HIV Infections; Humans; Male; Middle Aged; Radius; Tenofovir; Tibia; Tomography, X-Ray Computed | 2016 |
Determinants of bone diseases in tenofovir-treated HIV patients.
Topics: Adenine; Anti-HIV Agents; Bone Diseases; HIV Infections; Humans; Tenofovir | 2016 |
Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens.
Topics: Adult; Antiretroviral Therapy, Highly Active; Bone Diseases; Comorbidity; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Population Surveillance; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Tablets; Tenofovir; United States | 2016 |
Tenofovir: new indication. In chronic hepatitis B: beware bone toxicity.
Topics: Adenine; Antiviral Agents; Bone and Bones; Bone Diseases; Double-Blind Method; Drug Approval; Europe; Fractures, Bone; Hepatitis B, Chronic; Humans; Organophosphonates; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Tenofovir; Viremia; Virus Replication | 2009 |
Low bone mineral density with tenofovir: does statistically significant mean clinically significant?
Topics: Adenine; Adult; Anti-HIV Agents; Bone Density; Bone Diseases; Female; Fractures, Bone; HIV Infections; Humans; Incidence; Male; Organophosphonates; Tenofovir | 2010 |
Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndrome.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Diseases; Fanconi Syndrome; Female; Femoral Neck Fractures; HIV Infections; Humans; Middle Aged; Organophosphonates; Tenofovir | 2007 |